List All Salivary Gland Cancer Trials

Salivary Gland Cancer

 

MK-3475 Combined with Vorinostat for Metastatic Squamous Cell Head and Neck Cancer (9383)
A single arm Phase I/II study of MK-3475 combined with vorinostat for recurrent unresectable and/or metastatic squamous cell head and neck cancer and recurrent unresectable and/or metastatic salivary gland malignancies

Investigator: Cristina Rodriguez, MD;   Conditions: Head and Neck Cancer;    Status: Recruiting;   Study ID: NCT02538510